MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH reduced its stake in shares of MetLife, Inc. (NYSE:MET – Free Report) by 30.9% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 403,664 shares of the financial services provider’s stock after selling 180,458 shares during the quarter. MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH owned 0.06% of MetLife worth $32,903,000 at the end of the most recent quarter.
Other hedge funds have also recently bought and sold shares of the company. MeadowBrook Investment Advisors LLC increased its stake in MetLife by 244.4% in the third quarter. MeadowBrook Investment Advisors LLC now owns 310 shares of the financial services provider’s stock valued at $26,000 after acquiring an additional 220 shares during the period. Carmichael Hill & Associates Inc. grew its holdings in MetLife by 131.9% during the 3rd quarter. Carmichael Hill & Associates Inc. now owns 327 shares of the financial services provider’s stock worth $27,000 after acquiring an additional 186 shares during the last quarter. Wolff Wiese Magana LLC raised its stake in shares of MetLife by 374.3% in the third quarter. Wolff Wiese Magana LLC now owns 351 shares of the financial services provider’s stock worth $29,000 after acquiring an additional 277 shares during the last quarter. Peterson Financial Group Inc. bought a new stake in shares of MetLife during the third quarter valued at approximately $30,000. Finally, Retirement Wealth Solutions LLC acquired a new stake in shares of MetLife in the fourth quarter valued at approximately $32,000. 94.99% of the stock is owned by institutional investors.
Analyst Ratings Changes
A number of research analysts have commented on the company. TD Cowen increased their price objective on MetLife from $97.00 to $99.00 and gave the company a “buy” rating in a research report on Wednesday, November 27th. BMO Capital Markets assumed coverage on MetLife in a research report on Thursday. They issued a “market perform” rating and a $97.00 price objective for the company. JPMorgan Chase & Co. raised their target price on shares of MetLife from $86.00 to $88.00 and gave the company an “overweight” rating in a research note on Tuesday, January 7th. Wells Fargo & Company cut their price objective on shares of MetLife from $93.00 to $92.00 and set an “overweight” rating on the stock in a report on Tuesday, January 14th. Finally, StockNews.com lowered shares of MetLife from a “buy” rating to a “hold” rating in a report on Thursday, January 9th. Two equities research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $90.46.
MetLife Trading Up 1.2 %
NYSE:MET opened at $86.82 on Friday. The company has a debt-to-equity ratio of 0.51, a current ratio of 0.16 and a quick ratio of 0.16. The business’s 50-day simple moving average is $83.68 and its 200-day simple moving average is $79.82. MetLife, Inc. has a fifty-two week low of $64.61 and a fifty-two week high of $89.05. The stock has a market capitalization of $60.11 billion, a PE ratio of 17.50, a price-to-earnings-growth ratio of 0.65 and a beta of 1.07.
MetLife Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 11th. Investors of record on Tuesday, February 4th will be issued a dividend of $0.545 per share. The ex-dividend date of this dividend is Tuesday, February 4th. This represents a $2.18 dividend on an annualized basis and a dividend yield of 2.51%. MetLife’s payout ratio is 43.95%.
About MetLife
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Featured Articles
- Five stocks we like better than MetLife
- How to Invest in Insurance Companies: A GuideĀ
- 3 Buy-and-Hold Stocks for Long-Term Growth
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Despite Short-Term Risks Freeport McMoran Worth a Look
- The Basics of Support and Resistance
- 3 Lean and Mean Stocks Generating Over $1M in Revenue Per Worker
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET – Free Report).
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.